ERS clinical practice guidelines on treatment of sarcoidosis
Robert P. Baughman(University of Cincinnati), Daniel R. Ouellette(National Institutes of Health), Peter Korsten(Universitätsmedizin Göttingen), Thomy Tonia(University of Bern), Paola Rottoli(University of Siena), Ginger Spitzer(Pulmonary Fibrosis Foundation), Bernd Quadder, Francesco Bonella(Ruhrlandklinik), Marjolein Drent(Maastricht University), David Rigau(Iberoamerican Cochrane Centre), Marc A. Judson(Cleveland Clinic), Alexander G. Mathioudakis(Manchester University NHS Foundation Trust), Κατερίνα Αντωνίου(University of Crete), Dominique Valeyre(Inserm), Blin Nagavci(European Society of Clinical Microbiology and Infectious Diseases), Wim Wuyts(Universitair Ziekenhuis Leuven), Athol U. Wells(St Thomas' Hospital), Jan C. Grutters(University Medical Center Utrecht), Daniel A. Culver(Cleveland Clinic), Dominique Israël‐Biet(Délégation Paris 5), F Martone(Associazione Italiana Vulvodinia Onlus), Elyse E. Lower(University of Cincinnati)
Cited by 579
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension
|European Heart Journal|2022|3.6k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k